 enterovir rna sequenc polymeras chain reaction muscl patient postvir fatigu syndrom object presenc enterovir sequenc muscl patient postvir fatigu syndrom design detect sequenc polymeras chain reaction well group patient syndrom control period set institut neurolog glasgow subject consecut patient institut postvir fatigu syndrom undergon extens investig condit control catchment area evid fatigu undergo routin surgeri main outcom measur routin investig serolog screen antibodi rang virus presenc enterovir rna sequenc muscl biopsi specimen result patient control import serolog find patient antibodi titr equal posit enterovir rna sequenc neg posit epstein-barr viru specif igm posit neg six control similar neutralis antibodi coxsackievirus neg posit epstein-barr viru specif igm neg titr complement antibodi equal neg overal patient control enterovir rna sequenc muscl odd confid interv durat diseas patient age titr antibodi conclus persist enterovir infect muscl patient postvir fatigu syndrom aetiolog role